Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common cause of nosocomial pneumonia. In an industry-supported study, researchers in the U.S. and Spain analyzed data on patients with MRSA ventilator-associated pneumonia (VAP) from two randomized, double-blind trials in which vancomycin was compared with linezolid (both plus aztreonam) in patients with nosocomial pneumonia. These …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
